Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets.
Company facts
| Company | Agilent Technologies, Inc. |
|---|---|
| Symbol | A |
| Exchange | XNYS |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market cap | $40.35B (Massive market data, 2026-09-10) |
| Employees | 18,200 |
| Country | United States |
| Website | https://www.agilent.com |
Trading — Agilent Technologies, Inc.
| Last price | $146.93 |
|---|---|
| Change | 2.66% |
| Previous close | $143.12 |
| Day range | $144.48 – $146.98 |
| 50-day average | $143.26 |
| 200-day average | $131.57 |
| Average volume | 2,117,641 |
Price basis: yfinance_daily_bar_close · 2026-09-11T21:07:44.986755+00:00
Valuation and financial health
| Earnings per share | $5.11 |
|---|---|
| Price / book | 5.48 |
| Price / cash flow | 25.08 |
| Enterprise value / EBITDA | 22.27 |
| Enterprise value / sales | 5.77 |
| Debt / equity | 0.54 |
| Current ratio | 2.05 |
| Dividend yield | 0.71% |
| Free cash flow | $1.27B |
| Cash ratio | 0.77 |
| Enterprise value | $42.54B |
Reported 2026-09-10
Earnings
| Report date | 2026-11-23 |
|---|---|
| Session | After Hours |
| Fiscal quarter ending | 2026-10-31 |
| EPS estimate | 1.72 |
Source: optionsai supplemental public earnings calendar
Other Healthcare companies
Live data
Live quotes, options positioning, insider and congressional filings for A are on the IntelTrends dashboard.